Search results
Moderna stock gains on OpenAI deal (NASDAQ:MRNA)
Seeking Alpha· 4 days agoModerna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines. Read more here.
Moderna stock closes in green after eight sessions of losses (NASDAQ:MRNA)
Seeking Alpha· 5 days agoMaddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) closed in green and snapped an eight-day losing...
Cerity Partners LLC Grows Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 3 days agoCerity Partners LLC increased its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 106.6% during the 4th quarter, according to the company in its most recent ...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 2 days agoModerna's solid trial data makes me optimistic the FDA will offer mRNA-1345 a nod, so the company soon may have two products on the market -- and be...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 3 days agostock's 12-month performance. This means Moderna stock outranks almost half of all stocks on that...
Cwm LLC Has $11.77 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 days agoCwm LLC lifted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 27.1% during the fourth quarter, according to the company in its most recent Form 13F ...
CureVac (NASDAQ:CVAC) Shares Gap Up to $2.44
ETF DAILY NEWS· 4 days agoCureVac (NASDAQ:CVAC – Get Free Report) shares gapped up prior to trading on Monday . The stock had previously closed at $2.44, but opened at $2.51. CureVac shares last traded ...
CureVac to cut costs in restructuring
BioPharma Dive via Yahoo Finance· 4 days agoThe mRNA vaccine maker, which has lost most of its value since early 2021, is undergoing an “organizational redesign” that will eliminate 150 positions.
Applied DNA Announces 1-For-20 Reverse Stock Split
Digital Journal· 5 days ago(NASDAQ:APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-20 stock split of its common stock ...
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Zacks via Yahoo Finance· 2 days agoOver the past six months, shares of MRNA have risen 36.47%. (See the last biotech stock roundup...
